Table 2

Reasons for DMARD discontinuation among 19 prior-users
N (%) Side effects experienced Physician’s request Cost Concernsa Inconvenient Ineffective Otherb
Methotrexate 10 (52.6) 5 1 2 1 1 2 0
Hydroxychloroquine 6 (31.6) 1 2 0 1 0 2 1
Abatacept 1 (5.3) 0 0 0 0 0 1 0
Etanercept 2 (10.5) 0 0 0 0 0 1 1
Infliximab 1 (5.3) 0 0 0 0 0 1 0
Gold 4 (21.1) 1 1 0 1 0 1 1
Totalc 24 7 4 2 3 1 8 3

aConcerns about possible side effects or drug reactions that were not already experienced.

bOther health problems.

cParticipants were allowed to report more than one DMARD discontinuation.

Brown et al.

Brown et al. Arthritis Research & Therapy 2014 16:R30   doi:10.1186/ar4459

Open Data